PDCD1 and neoplasm: Five of seven mice had no measurable tumor at the end of the experiment, and all mice treated with TCR-Ts expressing PD1-41BB survived until the end of the experiment, whereas all mice in the other two groups had to be sacrificed between three and five weeks due to large tumor burdens.